3.9 Editorial Material

What is the role of microbial infection in Alzheimer's disease?

Related references

Note: Only part of the references are listed.
Article Clinical Neurology

Receptor for Advanced Glycation End Products (RAGE) Mediates Cognitive Impairment Triggered by Pneumococcal Meningitis

Vijayasree V. Giridharan et al.

Summary: Pneumococcal meningitis can disrupt the blood-brain barrier and increase the expression of RAGE in the brain, leading to neurological inflammation and cognitive impairment. Targeted inhibition of RAGE can alleviate symptoms in surviving rats with meningitis.

NEUROTHERAPEUTICS (2021)

Review Medicine, General & Internal

Alzheimer's disease

Philip Scheltens et al.

Summary: Alzheimer's disease is projected to see a significant increase in prevalence in the future, with genetics playing a key role. Novel biomarkers and lifestyle-based prevention trials show promising therapeutic potential. Promising pharmacological treatments are advancing in clinical trials, targeting amyloid beta, tau, and inflammation.

LANCET (2021)

Article Multidisciplinary Sciences

The innate immunity protein IFITM3 modulates γ-secretase in Alzheimer's disease

Ji-Yeun Hur et al.

NATURE (2020)

Article Biochemistry & Molecular Biology

Receptor for advanced glycation end products mediates sepsis-triggered amyloid-β accumulation, Tau phosphorylation, and cognitive impairment

Juciano Gasparotto et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2018)

Article Cell Biology

Amyloid-β peptide protects against microbial infection in mouse and worm models of Alzheimer's disease

Deepak Kumar Vijaya Kumar et al.

SCIENCE TRANSLATIONAL MEDICINE (2016)

Article Biochemical Research Methods

Immunodesign of experimental sepsis by cecal ligation and puncture

Daniel Rittirsch et al.

NATURE PROTOCOLS (2009)